IFNA1 and systemic lupus erythematosus: Furthermore, in SLE the presence of autoantibodies specific for RNA binding proteins has been demonstrated to amplify IFN production [86], and it is unknown at present whether vaccine mRNA in complex with preformed RNA-binding proteins may ultimately result in immune complexes with resultant pathologic inflammation in such settings.